Licensure

  • Connecticut Pharmacy License — facility license, active
  • Federal DEA Registration — Schedules II–V, active
  • NABP DSCSA / VAWD verification — pending facility activation
  • Connecticut Department of Consumer Protection registration — active

Accreditation

  • URAC Specialty Pharmacy Accreditation — in process. Pre-assessment complete; full submission target: Q3 2027.
  • ACHC Accreditation — under evaluation for parallel pursuit
  • Joint Commission Ambulatory Care Accreditation — under evaluation, post-launch

Payor Credentials

Commercial

  • Anthem Blue Cross Blue Shield of Connecticut — credentialing in progress
  • Aetna — credentialing in progress
  • Cigna — credentialing in progress
  • UnitedHealthcare — credentialing in progress
  • ConnectiCare — credentialing in progress

Government

  • Medicare Part B — enrollment in progress
  • Medicare Part D — pending URAC accreditation
  • Connecticut Medicaid — credentialing in progress

PBM Specialty Networks

  • CVS Caremark — pending URAC
  • Express Scripts / Accredo — pending URAC
  • OptumRx — pending URAC
  • Prime Therapeutics — pending URAC

Quality and Compliance Standards

TheraVite’s clinical operations are designed to meet or exceed:

  • USP General Chapter <797> standards for sterile compounding (immediate-use exemption applicable)
  • USP General Chapter <800> standards for hazardous drug handling
  • FDA 21 CFR 211 (cGMP) standards for drug storage and handling
  • FDA 21 CFR 312 standards informing chain-of-custody and lot-level documentation
  • HIPAA Privacy and Security Rule
  • FDA MedWatch standards for adverse event reporting

This page is updated monthly. For copies of current credentials, accreditation documentation, or to initiate a credentialing inquiry, contact info@theravitehealth.com.